176 related articles for article (PubMed ID: 29587865)
21. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
22. MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.
Cai W; Zhou D; Wu W; Tan WL; Wang J; Zhou C; Lou Y
BMC Genomics; 2018 Aug; 19(1):582. PubMed ID: 30075702
[TBL] [Abstract][Full Text] [Related]
23. Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma.
Kim EY; Kim A; Lee G; Lee H; Chang YS
BMC Cancer; 2018 Dec; 18(1):1221. PubMed ID: 30522449
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.
Jurmeister P; Schöler A; Arnold A; Klauschen F; Lenze D; Hummel M; Schweizer L; Bläker H; Pfitzner BM; Mamlouk S; Sers C; Denkert C; Stichel D; Frost N; Horst D; von Laffert M; Capper D
Mod Pathol; 2019 Jun; 32(6):855-865. PubMed ID: 30723296
[TBL] [Abstract][Full Text] [Related]
25. Primary Enteric Adenocarcinoma Lung with Mesenchymal Epithelial Transition Factor Amplification: A Case Report.
Shukla S; Pandey RK; Husain N; Srivastava A
Gulf J Oncolog; 2021 May; 1(36):76-78. PubMed ID: 35017140
[TBL] [Abstract][Full Text] [Related]
26. Lung adenocarcinoma: Sustained subtyping with immunohistochemistry and EGFR, HER2 and KRAS mutational status.
Sousa V; Rodrigues C; Silva M; Alarcão AM; Carvalho L
Rev Port Pneumol (2006); 2015; 21(3):113-25. PubMed ID: 25926253
[TBL] [Abstract][Full Text] [Related]
27. Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma.
Bian T; Zhao J; Feng J; Zhang Q; Qian L; Liu J; Jiang D; Liu Y; Zhang J
Oncotarget; 2017 Sep; 8(38):63442-63452. PubMed ID: 28969003
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.
Paner GP; McKenney JK; Barkan GA; Yao JL; Frankel WL; Sebo TJ; Shen SS; Jimenez RE
Am J Surg Pathol; 2011 Jun; 35(6):787-98. PubMed ID: 21572312
[TBL] [Abstract][Full Text] [Related]
29. Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.
Abe M; Watanabe K; Shinozaki-Ushiku A; Ushiku T; Abe T; Fujihara Y; Amano Y; Zong L; Wang CP; Kubo E; Inaki R; Kinoshita N; Yamashita S; Takai D; Ushijima T; Nagase T; Hoshi K
BMC Cancer; 2019 Jan; 19(1):52. PubMed ID: 30634950
[TBL] [Abstract][Full Text] [Related]
30. CK7/CK20 Double-Negative Pulmonary Enteric Adenocarcinoma With Histopathological Evaluation of Transformation Zone Between Enteric Adenocarcinoma and Conventional Pulmonary Adenocarcinoma.
Miyaoka M; Hatanaka K; Iwazaki M; Nakamura N
Int J Surg Pathol; 2018 Aug; 26(5):464-468. PubMed ID: 29411669
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland.
Grosse A; Grosse C; Rechsteiner M; Soltermann A
Diagn Pathol; 2019 Feb; 14(1):18. PubMed ID: 30744664
[TBL] [Abstract][Full Text] [Related]
32. Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series.
Ericson-Lindquist K; Johansson A; Levéen P; Elmberger G; Jönsson G; Staaf J; Brunnström H
Diagn Pathol; 2017 Mar; 12(1):31. PubMed ID: 28347348
[TBL] [Abstract][Full Text] [Related]
33. High-grade fetal adenocarcinoma of the lung is a tumour with a fetal phenotype that shows diverse differentiation, including high-grade neuroendocrine carcinoma: a clinicopathological, immunohistochemical and mutational study of 20 cases.
Suzuki M; Yazawa T; Ota S; Morimoto J; Yoshino I; Yamanaka S; Inayama Y; Kawabata Y; Shimizu Y; Komatsu M; Notohara K; Koda K; Nakatani Y
Histopathology; 2015 Dec; 67(6):806-16. PubMed ID: 25851923
[TBL] [Abstract][Full Text] [Related]
34. Tumour Genome Characterization of a Rare Case of Pulmonary Enteric Adenocarcinoma and Prior Colon Adenocarcinoma.
Smyth RJ; Thomas V; Fay J; Ryan R; Nicholson S; Morgan RK; Grogan L; Breathnach O; Morris PG; Toomey S; Hennessy BT; Furney SJ
J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442412
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status.
Kim H; Yang JM; Jin Y; Jheon S; Kim K; Lee CT; Chung JH; Paik JH
Oncotarget; 2017 Jan; 8(5):8484-8498. PubMed ID: 28035073
[TBL] [Abstract][Full Text] [Related]
36. Hyperprogressive Disease After Immunotherapy: A Case Report of Pulmonary Enteric Adenocarcinoma.
Hu CH; Shi S; Dong W; Xiao L; Zang H; Wu F
Front Oncol; 2022; 12():799549. PubMed ID: 35321429
[TBL] [Abstract][Full Text] [Related]
37. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
Preusser M; Berghoff AS; Koller R; Zielinski CC; Hainfellner JA; Liebmann-Reindl S; Popitsch N; Geier CB; Streubel B; Birner P
Eur J Cancer; 2015 Sep; 51(13):1803-11. PubMed ID: 26164066
[TBL] [Abstract][Full Text] [Related]
38. [Leptomeningeal metastasis of EGFR (+) lung adenocarcinoma: a case report].
Güçsav MO; Ayrancı A; Polat G; Karadeniz G; Demirci Üçsular F; Öztekin Ö; Bozkurt MT; Akyol M; Yalnız E
Tuberk Toraks; 2018 Dec; 66(4):340-344. PubMed ID: 30683030
[TBL] [Abstract][Full Text] [Related]
39. SATB2 is a supplementary immunohistochemical marker to CDX2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary.
Dabir PD; Svanholm H; Christiansen JJ
APMIS; 2018 Jun; 126(6):494-500. PubMed ID: 29924451
[TBL] [Abstract][Full Text] [Related]
40. Use of SuperARMS EGFR Mutation Detection Kit to Detect EGFR in Plasma Cell-free DNA of Patients With Lung Adenocarcinoma.
Cui S; Ye L; Wang H; Chu T; Zhao Y; Gu A; Xiong L; Shi C; Jiang L
Clin Lung Cancer; 2018 May; 19(3):e313-e322. PubMed ID: 29329944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
